13C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns

NMR in Biomedicine

Volumn 24, Issue 10, 2011, Pages 1243-1252

  Grinde, Maria T ^a,b   Moestue, Siver A ^a   Borgan, Eldrid ^a,c,d   Risa, Øystein ^a   Engebraaten, Olav ^d,e,f   Gribbestad, Ingrid S ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

13C MRS; Alanine; Breast cancer; Gene expression; Glycolysis; High resolution magic angle spinning MRS; Lactate; Xenograft

Indexed keywords

13C MRS; ALANINE; BREAST CANCER; GLYCOLYSIS; HIGH RESOLUTION MAGIC ANGLE SPINNING; LACTATE; XENOGRAFT;

AMINO ACIDS; C (PROGRAMMING LANGUAGE); DISEASES; GLUCOSE; MAMMALS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMORS;

GENE EXPRESSION;

ALANINE; ENZYME; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GALACTOSE MUTAROTASE; GLUCOSE; GLUTAMIC ACID; GLYCINE; LACTIC ACID; PHOSPHOGLYCERATE KINASE; UNCLASSIFIED DRUG; CARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; HIGH RESOLUTION MAGIC ANGLE SPINNING MAGNETIC RESONANCE SPECTROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS;

MUS;

ALANINE; ANIMALS; BREAST NEOPLASMS; CARBON ISOTOPES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, BIOLOGICAL; PRINCIPAL COMPONENT ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855319821     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1683     Document Type: Article

References (58)

1. Warburg O. On the origin of cancer cells. Science 1956;123(3191):309-314.
2. Warburg O, Posener K, Negelein E. Uber den Stoffwechsel der Tumoren. Biochem Z. 1924;152:319-344.
3. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'Shaughnessy J, Guyton KZ, Mankoff DA, Shankar L, Larson SM, Sigman CC, Schilsky RL, Sullivan DC. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 2005;11(8):2785-2808.
4. Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008;65(24):39810û3999.
5. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?Nat. Rev. Cancer 2004;4(11):891-899.
6. Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers.J. Nucl. Med. 2008;49 (Suppl 2):24S-42S.
7. Robey IF, Stephen RM, Brown KS, Baggett BK, Gatenby RA, Gillies RJ. Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia 2008;10(8):745-756.
8. Gillies RJ, Gatenby RA. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev. 2007;26(2):311-317.
9. Guppy M, Greiner E, Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 1993;212(1):95-99.
10. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001;51(2):349-353.
11. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, Mueller-Klieser W. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60(4):916-921.
12. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin. Cancer Res. 1996;2(7):1151-1154.
13. Rivenzon-Segal D, Margalit R, Degani H. Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS. Am. J. Physiol. Endocrinol. Metab. 2002;283(4):E623-630.
14. Shanmugam M, McBrayer SK, Rosen ST. Targeting the Warburg effect in hematological malignancies: from PET to therapy. Curr. Opin. Oncol. 2009;21(6):531-536.
15. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 2010;10(4):267-277.
16. Rivenzon-Segal D, Boldin-Adamsky S, Seger D, Seger R, Degani H. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int. J. Cancer 2003;107(2):177-182.
17. Young CD, Anderson SM. Sugar and fat - that's where it's at: metabolic changes in tumors. Breast Cancer Res. 2008;10(1):202.
18. Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R. High expression of inducible 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 2002;62(20):5881-5887.
19. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.J. Clin. Oncol. 2002;20(2):379-387.
20. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.J. Nucl. Med. 1996;37(6):1042-1047.
21. El-Bacha T, de Freitas MS, Sola-Penna M. Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Mol. Genet. Metab. 2003;79(4):294-299.
22. Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl. Med. Biol. 1994;21(6):827-834.
23. Rempel A, Mathupala SP, Griffin CA, Hawkins AL, Pedersen PL. Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res. 1996;56(11):2468-2471.
24. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. U S A 2010;107(5):2037-2042.
25. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9(6):425-434.
26. Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM. Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Mol. Cancer 2009;8:41.
27. Miccheli A, Tomassini A, Puccetti C, Valerio M, Peluso G, Tuccillo F, Calvani M, Manetti C, Conti F. Metabolic profiling by 13C-NMR spectroscopy: [1, 2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie 2006;88(5):437-448.
28. Pfeuffer J, Lin JC, Delabarre L, Ugurbil K, Garwood M. Detection of intracellular lactate with localized diffusion {1H-13C}-spectroscopy in rat glioma in vivo.J. Magn. Reson. 2005;177(1):129-138.
29. Griffin JL, Corcoran O. High-resolution magic-angle spinning 13C NMR spectroscopy of cerebral tissue. MAGMA 2005;18(1):51-56.
30. Risa O, Melo TM, Sonnewald U. Quantification of amounts and (13)C content of metabolites in brain tissue using high- resolution magic angle spinning (13)C NMR spectroscopy. NMR Biomed. 2009;22(3):266-271.
31. Bergamaschi A, Hjortland GO, Triulzi T, Sorlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O. Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Mol. Oncol. 2009;3(5-6):469-482.
32. Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Borresen-Dale AL, Engebraaten O, Maelandsmo GM, Gribbestad IS. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 2010;10(1):433.
33. Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006;49(1):22-34.
34. Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur. J. Cancer 2004;40(18):2667-2675.
35. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR, Mross F, Dieterich H, Seitz R, Ross D, Botstein D, Brown P. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am. J. Pathol. 2002;161(6):1991-1996.
36. Engebraaten O, Hjortland GO, Martinsen M, Halvorsen T, Fodstad O, Ree AH. Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion. Poster in The Third International Symposium on the Molecular Biology of Breast Cancer. Molde, Norway, 2005.
37. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324(5930):1029-1033.
38. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002;15(5):327-337.
39. Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, Llacer JL, Piotto M, Assemat O, Celda B.1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas. NMR Biomed. 2004;17(4):191-205.
40. Forshed J, Schuppe-Koistinen I, Jacobsson SP. Peak alignment of NMR signals by means of a genetic algorithm. Analytica Chimica Acta 2004;487:189-199.
41. Lee GC, Woodruff DL. Beam search for peak alignment of NMR signals. Analytica Chimica Acta 2004;513:413-416.
42. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004;3: Article3.
43. Yalcin A, Telang S, Clem B, Chesney J. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatases in cancer. Exp. Mol. Pathol. 2009;86(3):174-179.
44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.J.R. Statist. Soc. B 1995;57(1):289-300.
45. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207-210.
46. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. U S A 1994;91(14):6379-6383.
47. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005;8(4):311-321.
48. Cheng LL, Chang IW, Smith BL, Gonzalez RG. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.J. Magn. Reson. 1998;135(1):194-202.
49. Toyooka M, Kimura H, Uematsu H, Kawamura Y, Takeuchi H, Itoh H. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Clin. Imaging 2008;32(4):251-258.
50. Wamelink MM, Struys EA, Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.J. Inherit. Metab. Dis. 2008;31(6):703-717.
51. Hassel B, Sonnewald U, Fonnum F. Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic study.J. Neurochem. 1995;64(6):2773-2782.
52. Krebs HA. The Pasteur effect and the relations between respiration and fermentation. Essays Biochem. 1972;8:1-34.
53. Zancan P, Sola-Penna M, Furtado CM, Da Silva D. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab. 2010;100(4):372-378.
54. Minchenko OH, Opentanova IL, Ogura T, Minchenko DO, Komisarenko SV, Caro J, Esumi H. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 in mammary gland malignant cell lines. Acta Biochim. Pol. 2005;52(4):881-888.
55. Yeh CS, Wang JY, Chung FY, Lee SC, Huang MY, Kuo CW, Yang MJ, Lin SR. Significance of the glycolytic pathway and glycolysis related-genes in tumorigenesis of human colorectal cancers. Oncol. Rep. 2008;19(1):81-91.
56. Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004;84(6):1014-1020.
57. Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I, Nakamura K. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 2007;30(4):849-855.
58. Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Bofin A, Mælandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS. In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Doctoral theses at NTNU, 2010;233. Huuse, EM.